Navigation Links
Capacity in Medical Technology

Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)

... ITMN ) reported that results from the two Phase 3 capacity studies evaluating pirfenidone in patients with ... in San Diego. Dr. Paul Noble, co-chair of the capacity program and Professor of Medicine and Chief of ... Medical Center presented details of data from capacity that were previously announced by the company in ...

Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand

... on the previously unmet process, facility and capacity needs of the $2 billion highly-niched, low-volume ... waiting years to build additional sterile filling capacity to address clinical and commercial capacity needs of large pipelines no longer remains ...

Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease

... vascular resistance (PVR) and exercise capacity (6MWD). Disease progression was assessed by the ... Class III and IV to improve exercise capacity and decrease the rate of clinical worsening and ... in PAH Functional Class III to improve exercise capacity and symptoms. In the EU Tracleer(R) is ...

InterMune Announces Progress on Pirfenidone in IPF

... - Initiating planned roll-over study for capacity patients in Q3 - - Patient retention and conduct of Phase 3 capacity program remain excellent ... who complete one of the two concurrent Phase 3 capacity studies of pirfenidone in IPF. InterMune expects ...

Reduced Lung Capacity Accelerates With Diabetes

... who have diabetes encounter a faster loss of lung capacity than those who do not have diabetes, a finding ... or LDL ("bad cholesterol"). Reduced Lung capacity in People With Diabetes The lung research, ... the same authors established that decreased lung capacity precedes and may predict a diagnosis of diabetes. ...

On World AIDS Day, CHF International Calls for Community Mobilization and Local Capacity Building to Fight HIV/AIDS

... and build the technical and organizational capacity of frontline providers to provide ... organizations' technical and organizational capacity and information sharing and referral mechanisms. ... of care through HIV and AIDS. In addition to capacity building, CHAMP focuses on increasing access to ...

NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020

... the first second of forced exhalation; Slow Vital capacity (SVC), the amount of air that can be forcibly ... in as deeply as possible and Inspiratory capacity (IC), the maximum volume of air that can be ... the first second of forced exhalation; Slow Vital capacity (SVC), the amount of air that can be forcibly ...

BD and PEPFAR Collaborate to Strengthen Laboratory Systems in Fight Against HIV/AIDS and TB

... In addition to improving laboratory capacity for HIV/AIDS testing and monitoring, BD and ... allow PEPFAR to increase laboratory capacity 15-20% over current levels. About PEPFAR The ... living with HIV; and build technical and human capacity and infrastructure to address the global HIV/AIDS ...

Bethesda-Based NHSi Wins $2M Grant for Blood Technology

... can deliver higher-quality, more physiologic blood, with an improved capacity to deliver oxygen and more deformable red blood cells for better capillary ... red blood cells stored for transfusion. Red blood cells' diminished capacity to deform and perfuse narrow capillary networks in tissues is believed to ...

Genomas Clinical Study Finds Increased Prevalence of Drug Metabolism Deficiencies in Patients With Serious Psychotropic Side Effects

... for DNA typing because their common variants result in deficient metabolic capacity for many psychotropic drugs. Combinatorial gene analysis revealed that 57 ... of multiple gene variations associated with no or poor drug metabolism capacity on 2 or 3 genes compared to 36 percent of individuals in the control ...

Isogen Launches Major New Facility to Address Global Biopharma Demand

... Isogen was founded to specifically address the process, facility and capacity problems commonly associated with the $2 billion highly-niched, low-volume ... fill lines in a potent capable facility. Isolator-based lyophilization capacity is planned for later in 2009. The January 21st facility launch sets a ...

Just in Time for Winter, a New Berry That's Good for Your Health

... Department of Agriculture (USDA), elderberries have twice the antioxidant capacity of blueberries and significantly more than the capacity of cranberries. Throughout history black elderberry has been used to treat ...

MonoSol Rx Completes Thin Film Escitalopram Oxalate Pilot Product Development

... of the Company's self- funded initiatives designed to capitalize on our capacity to develop and manufacture thin film prescription products at commercial ... integrated development and production infrastructure, MonoSol Rx has the capacity to manufacture OTC drug products for near-term revenues that enable the ...

Vical Advances RapidResponse(TM) DNA Vaccine Platform Under $6 Million Grant from NIH

... believes that the RapidResponse(TM) DNA platform can overcome the time, capacity and cost challenges of manufacturing conventional vaccines for diseases ... during the early stages of an infectious outbreak and overcome the time, capacity and cost challenges of manufacturing conventional vaccines; ...

InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA

... medical need. We look forward to reporting top-line results of our Phase 3 capacity program of pirfenidone in IPF, in January of 2009." Webcast and ... positive clinical trial results; (iii) the results of the InterMune capacity trials of pirfenidone may differ materially from those of the Shionogi & ...

Genetic Immunity Announces Data Related to the DermaVir Nanomedicine Patch in the Journal of Immunology

... Use of HIV-specific T cell Precursors with High Proliferative capacity (PHPC) Marker to Predict Reduction of Viral Load MCLEAN, Va., and ... measured by a novel assay of T cell Precursors with High Proliferative capacity (PHPC assay) better correlated with viral suppression and positive ...

Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study

... full protection from organophosphate poisoning, simulating the capacity of the plant cell expressed Acetylcholinesterase protein to treat nerve ... not only the clinical potential of Acetylcholinesterase but also the capacity of our ProCellEx(TM) plant cell expression system to generate a broad ...

Tengion Launches Third Phase 2 Clinical Trial of Regenerated Human Bladder

... major goals in bladder management of patients with OAB are to increase the capacity of the bladder, reduce the frequency of urination, and where relevant, ... have failed. The goal of surgery is to increase the functional capacity of the bladder with a view toward symptomatic and quality of life ...

Study Shows Need to Test More COPD and Asthma Patients for Underdiagnosed Pulmonary Disease

... (forced expiratory volume at 1 second) or a ratio of FEV1 to forced vital capacity (FEV1/FVC) of less than 70 percent. Blood tests were taken to assess ... criteria, including levels of FEV1, ratios of FEV1 to forced vital capacity (FEV1/FVC), or the number of bronchial infections within the past 12 ...

Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs

... that the RapidResponse(TM) DNA platform can overcome the time, capacity and cost challenges of manufacturing conventional vaccines for ... million doses of vaccines in a matter of days and overcome the time, capacity and cost challenges of manufacturing conventional vaccines; whether the ...

Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer

... by government investigations, litigation and products liability claims. We depend on third parties for a significant portion of our manufacturing capacity for the supply of certain of our current and future products and limits on supply may constrain sales of certain of our current products and product ...

NOVAVAX Achieves Pandemic H1N1 Influenza Production Milestone

... successful test of our VLP technology. With further scale up, recombinant influenza VLP vaccine technology has the potential to expand vaccine surge capacity and significantly reduce the timeline for vaccine release. We are proud of our staff who worked tirelessly to achieve this important milestone while ...

Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)

... by government investigations, litigation and products liability claims. We depend on third parties for a significant portion of our manufacturing capacity for the supply of certain of our current and future products and limits on supply may constrain sales of certain of our current products and product ...

Medigus and Tower Semiconductor Announce World's Smallest Medical Video Camera Based on Advanced CMOS Image Sensor

... Tower provides world-class customer service and maintains two fabrication facilities in Israel and a fab in Newport Beach, CA, with manufacturing capacity available in China through partnerships with ASMC and HHNEC. For more information, please visit http://www.towersemi.com and ...

Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center

... diseases, including renal disease and cancer. Keryx is developing Zerenex(TM)(ferric citrate), an oral, iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. Zerenex has recently completed a Phase 2 clinical program as a treatment for ...

GNC Unveils Study Results for First and Only Nitric Oxide Product Clinically Proven to Improve Physical Performance at NSCA Conference in Las Vegas

... of the double-blind placebo-controlled study was to examine the effects of daily administration of arginine-based supplements on the physical working capacity at the fatigue threshold (PWC(FT)). The PWC(FT) test estimates the highest power output that can be maintained without neuromuscular evidence of ...

Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With Bone Metastases

... by government investigations, litigation and products liability claims. We depend on third parties for a significant portion of our manufacturing capacity for the supply of certain of our current and future products and limits on supply may constrain sales of certain of our current products and product ...

King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use

... in federal and state laws and regulations; changes in competition; unexpected changes in technologies and technological advances; and manufacturing capacity constraints. Other important factors that may cause actual results to differ materially from the forward-looking statements are discussed in the ...

Cordex Signs European Development Partnership for ATPotent(TM) Sperm Motility Drug

... fertilization in the female reproductive tract. Cordex's sponsored studies have shown that ATP treatment can improve the motility and fertilization capacity of malfunctioning sperm obtained from infertile males due to asthenozoospermia as well as thawed sperm that had been cryopreserved. About ...

Alfacell Provides Shareholder Update

... to treatment. This propensity of Onconase makes it an attractive candidate to be used as an adjunct to variety of cancer treatment protocols. In this capacity Onconase can be widely used in therapy of different tumor types, including most common types such as cancer of breast, prostate, colon, ovary and ...

Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily

... ) today announced the results of a pivotal 16-week study showing that a once-daily dose of tadalafil was generally well tolerated, improved exercise capacity and improved time to clinical worsening in patients with pulmonary arterial hypertension (PAH)(1). The randomized, double-blind, 16-week, ...

Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer

... diseases, including renal disease and cancer. Keryx is developing Zerenex(TM)(ferric citrate), an oral, iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. Zerenex has recently completed a Phase 2 clinical program as a treatment for ...

Heart Disease Treatment Breakthrough

... that can cause heart attacks and stroke. Dozens of research studies have shown that lycopene - found in the skins of ripe tomatoes - has the capacity to significantly reduce the build up of plaque in the arteries that can lead to heart attacks and stroke. Lycopene is the potent antioxidant ...

Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer

... diseases, including renal disease and cancer. Keryx is developing Zerenex(TM)(ferric citrate), an oral, iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. Zerenex has recently completed a Phase 2 clinical program as a treatment for ...

Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401's Activity in the Treatment of Advanced Metastatic Renal Cell Cancer

... diseases, including renal disease and cancer. Keryx is developing Zerenex((TM)) (ferric citrate), an oral, iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. Zerenex has recently completed a Phase 2 clinical program as a treatment for ...

PARI Pharma's Nebulized DSCG Shows Results Similar to Inhaled Steroids in Asthma Studies Presented at ATS

... (MDI) via a holding chamber. The study compared various lung function parameters, such as forced expiratory volume in 1 sec (FEV1), forced vital capacity (FVC), mean expiratory flow (MEF 50% pred), inflammatory markers, such as serum percent Eosinophils and expired nitric oxide (FeNo), asthma symptom ...

First Jatropha Genome Completed by Synthetic Genomics Inc. and Asiatic Centre for Genome Technology

... its operations to Indonesia, on a joint venture basis, to develop some 98,300 hectares. The Asiatic Group also owns 5 oil mills with a total milling capacity of 235 tonnes per hour and is reputed to be one of the lowest cost palm oil producers with fresh fruits bunches production of over one million ....

CMC ICOS Biologics and Implicit Bioscience Ltd Announce IC14 Antibody Manufacturing Agreement and Patent License

... CHEF1(R) expression technology, a system that rapidly generates production cell lines and provides the flexibility to quickly increase manufacturing capacity as needed. Both agreements have been structured with an eye to future partnering for later stage clinical trials and commercialization. Garry ...

Jubilant Enters Research Collaboration With AstraZeneca

... Executive Vice-President, Global Discovery, at AstraZeneca says, "This collaboration complements our internal capabilities and increases the capacity of our pre-clinical programs. It is a concrete example of the innovative approaches we are taking to deliver a sustainable Discovery pipeline with a ...

USAID Cooperates in Pandemic Preparedness Initiative

... that will kick off the implementation stage of its Humanitarian Pandemic Preparedness initiative. The three-day exercise seeks to advance global capacity to thwart a humanitarian disaster in the event of a pandemic. As recently emphasized by outbreaks of swine flu and H5N1 avian influenza, the ...
Other Contents
(Date:7/11/2014)... with other group members to reduce aggression and gain ... strategy for grooming activities shows a certain pattern across ... scientific journal Biology Letters . , Grooming between ... without ulterior motives. To be groomed has hygienic benefits ... another individual can provide access to infants, mating opportunities ...
(Date:7/11/2014)... kidney injury related to the use of hydroxyethyl starch ... molecules, according to a report in Anesthesia & ... Society (IARS). , The "total mass of HES molecules" ... renal proximal tubule cells (PTCs), concludes the laboratory study ... Wrzburg, Austria. Other factorssuch as differences in the ...
(Date:7/11/2014)... Evidence exists that cannabinoid receptor type 1 ... Ca2+ influx, and reduce neurotransmitter release. However, ... 1 can increase extracellular Ca2+ influx and ... his team, Tongji Hospital Affiliated to Tongji ... Technology, China used whole cell voltage-clamp and ...
Breaking Biology News(10 mins):Baboons groom early in the day to get benefits later 2In lab studies, hydroxyethyl starch has direct harmful effects on kidney cells 2
(Date:7/14/2014)... 14, 2014 EnergyFirst, manufacturer ... company Permalean for its great products, thriving ... Permalean, which markets its products as Jim’s Permalean Protein ... part of EnergyFirst’s lineup of nutritional products. The ... the coming year. , Founded in 1999, Permalean’s products ...
(Date:7/14/2014)... New research and analysis from the national ... examines toxic ingredients in tampons, a product used ... chemicals that may be found in the product’s absorptive ... put women’s health at risk. , According to ... , the potential impact of toxic chemical exposure from ...
(Date:7/13/2014)... FORT LEE, N.J. – Authors Leonard I. ... the science of tooth implants in their book ... describes recent advances and techniques in the world of dentistry ... who have lost all of their natural teeth. , Dr. ... subperiosteal implant in 1940. It was a mesh frame ...
(Date:7/13/2014)... 2014 MED-Ed Facilities is seeking proposals ... conference, April 7+8 in Boston at the Seaport Hotel. ... recent event. Presentations by individuals or teams are welcome. ... the types of sessions that were presented last year, ... proposal today! , Conference Director, The successful planning ...
(Date:7/13/2014)... Worldwide ladies are extremely responsive to Angeldress.co.uk’s pink ... approach and has created a lot of new items ... choices that responded directly to customers’ demands. , ... apparels. The company’s pink bridesmaid dresses come in many ... create the best products for customers from around the ...
Breaking Medicine News(10 mins):Health News:EnergyFirst Acquires Permalean - Manufacturer of All Natural Protein Bars and Powders 2Health News:EnergyFirst Acquires Permalean - Manufacturer of All Natural Protein Bars and Powders 3Health News:New Patent Analysis Shows Toxic Risk From Tampons 2Health News:New Patent Analysis Shows Toxic Risk From Tampons 3Health News:New Patent Analysis Shows Toxic Risk From Tampons 4Health News:New Patent Analysis Shows Toxic Risk From Tampons 5Health News:Authors Leonard I. Linkow and Sheldon Winkler Feature Advancements in Implant Dentistry 2Health News:Authors Leonard I. Linkow and Sheldon Winkler Feature Advancements in Implant Dentistry 3Health News:Authors Leonard I. Linkow and Sheldon Winkler Feature Advancements in Implant Dentistry 4Health News:MED-Ed Facilities Conference Call for Speakers Open 2Health News:Angeldress.co.uk Announces Summer Sale For Pink And Red Bridesmaid Dresses; The Current Discount Is Up To 80% Off 2
Other TagsOther Tags